QVC Group Chapter 11 Files in Prepackaged Restructuring

QVC Group Chapter 11 begins a prepackaged debt restructuring to slash leverage and forces creditor recoveries while heightening Nasdaq delisting risk.

April 17, 2026·2 min read
View all news articles
Centered flat vector of a dimming smart TV panel symbolizing QVC Group Chapter 11 restructuring and debt reduction.

KEY TAKEAWAYS

  • Filed a prepackaged Chapter 11 to cut principal debt from $6.6 billion to $1.3 billion.
  • Restructuring follows an RSA with majority lenders and targets emergence within approximately 90 days.
  • The 10-K warned capital stock was expected to become worthless and Nasdaq delisting was expected.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

QVC Group filed for Chapter 11 on April 16, 2026, initiating a prepackaged restructuring to sharply reduce its debt while maintaining operations across its U.S. retail brands, the company said in a press release.

Prepackaged Restructuring and Timeline

QVC Group executed a Restructuring Support Agreement (RSA) with its majority lenders and filed voluntary prepackaged Chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of Texas. The filings cover QVC Group, Inc. and certain U.S. subsidiaries; international operations are excluded.

The plan reduces the company’s principal debt from $6.6 billion as of December 31, 2025, to $1.3 billion after emergence. The company reported domestic cash and cash equivalents exceeding $1 billion at that date. The RSA targets emergence within approximately 90 days, with the prepackaged structure designed for expedited completion.

Creditors, Employees, and Equity

QVC Group said all third-party general unsecured creditors will be paid in full or reinstated unimpaired, and vendors and suppliers will receive full payment for goods and services during the proceedings. The company emphasized the plan aims to preserve supplier relationships and ensure uninterrupted product flow.

Management reported ample liquidity to meet business obligations throughout the court-supervised process. It filed customary motions to continue employee wage and benefit payments and said no layoffs or furloughs are planned; employees will receive wages and benefits without interruption.

The company’s 2025 Form 10-K warns its capital stock is expected to become worthless. Current equity holders are likely to face minimal or no recovery, and QVC Group expects Nasdaq delisting during the bankruptcy process.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Nebius Convertible Notes Proposal Draws Scrutiny

Nebius Convertible Notes Proposal Draws Scrutiny

Nebius convertible notes private offering and planned share-exchange announced Aug. 19, 2026, raising dilution concerns and weighing on AI-cloud sentiment.

Marvell Google Chip Deal Includes $12.2B Warrant

Marvell Google Chip Deal Includes $12.2B Warrant

Marvell Google Chip Deal includes a $12.2B equity warrant that ties Marvell upside to Google purchase milestones and repositions trader flow expectations.

Amazon Drone Delivery Expands to Nearly 500 Cities

Amazon Drone Delivery Expands to Nearly 500 Cities

Amazon drone delivery will reach nearly 500 U.S. cities by end 2026, expanding Prime Air's reach and pressuring last-mile logistics.

Anthropic Revenue Tops OpenAI, Fuels IPO Hype

Anthropic Revenue Tops OpenAI, Fuels IPO Hype

Anthropic revenue surge put the company ahead of OpenAI in quarterly sales, accelerating IPO speculation and pressuring AI valuations and flows.

Estée Lauder Earnings Beat, China Demand Raises Outlook

Estée Lauder Earnings Beat, China Demand Raises Outlook

Estée Lauder earnings beat Q4 estimates and raised fiscal 2027 guidance; premium fragrances and China demand widened margins and spurred trading momentum.

Merck Moderna Melanoma Vaccine Meets Topline Goals

Merck Moderna Melanoma Vaccine Meets Topline Goals

Merck Moderna melanoma vaccine met primary and key secondary endpoints; companies will present data and engage regulators, creating a filing catalyst.